Aberrant DNA Methylation in Hereditary Nonpolyposis Colorectal Cancer Without Mismatch Repair Deficiency

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Goel, Ajay ^a   Xicola, Rosa M ^b   Nguyen, Thuy Phuong ^a   Doyle, Brian J ^b   Sohn, Vanessa R ^b   Bandipalliam, Prathap ^c   Rozek, Laura S ^d   Reyes, Josep ^e   Cordero, Carmen ^f   Balaguer, Francesc ^a   Castells, Antoni ^g   Jover, Rodrigo ^h   Andreu, Montserrat ⁱ   Syngal, Sapna ^c   Boland, C Richard ^a   Llor, Xavier ^b  

^a Baylor University   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Hospital Comarcal d'Inca   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

Author keywords

Colorectal Cancer; Microsatellite Stable, Hereditary Nonpolyposis Colorectal Cancer; Non Lynch HNPCC

Indexed keywords

B RAF KINASE; K RAS PROTEIN; LONG INTERSPERSED NUCLEOTIDE ELEMENT 1 PROTEIN; NEUROGENIN 1; PROTEIN CACNAG1; PROTEIN MLH1; RAF PROTEIN; RAS PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; COLON CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FAMILY HISTORY; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MALE; MICROSATELLITE MARKER; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 77951814373     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.01.035     Document Type: Article

References (44)

1. Xicola R.M., and Llor X. Hereditary colorectal cancer. In: Kim K. (Ed). Colorectal cancer: early detection and prevention (2009), Slack Inc, Thorofare, NJ 149-166
2. Vasen H.F., Mecklin J.P., Khan P.M., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34 (1991) 424-425
3. Vasen H.F.A., Watson P., Mecklin J.-P., et al. HNPCC I: new clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 (1999) 1453-1456
4. Beck N.E., Tomlinson I.P., Homfray T., et al. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg 84 (1997) 233-237
5. Chung D.C., and Rustgi A.K. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 138 (2003) 560-570
6. Kolodner R.D., Tytell J.D., Schmeits J.L., et al. Germ-line msh6 mutations in colorectal cancer. Cancer Res 59 (1999) 5068-5074
7. Nakagawa H., Lockman J.C., Frankel W.L., et al. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 64 (2004) 4721-4727
8. Aaltonen L.A., Peltomaki P., Leach F.S., et al. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812-816
9. Fishel R. Signaling mismatch repair in cancer. Nat Med 5 (1999) 1239-1241
10. Llor X., Pons E., Xicola R.M., et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11 (2005) 7304-7310
11. Mueller-Koch Y., Vogelsang H., Kopp R., et al. HNPCC-clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 14 (2005) 14
12. Lindor N.M., Rabe K., Petersen G.M., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 (2005) 1979-1985
13. Llor X., Pons E., Xicola R.M., et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11 (2005) 7304-7310
14. Abdel-Rahman W.M., Ollikainen M., Kariola R., et al. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 17 (2005) 17
15. Sanchez-de-Abajo A., de la Hoya M., van Puijenbroek M., et al. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Clin Cancer Res 13 (2007) 5729-5735
16. Goel A., Nagasaka T., Arnold C.N., et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132 (2007) 127-138
17. Nagasaka T., Koi M., Kloor M., et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 134 (2008) 1950-1960e1
18. Gylling A., Ridanpaa M., Vierimaa O., et al. Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer 124 (2009) 2333-2340
19. Feinberg A.P., and Vogelstein B. Alterations in DNA methylation in human colon neoplasia. Semin Surg Oncol 3 (1987) 149-151
20. Goelz S.E., Vogelstein B., Hamilton S.R., et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228 (1985) 187-190
21. Das P.M., and Singal R. DNA methylation and cancer. J Clin Oncol 22 (2004) 4632-4642
22. Xicola R.M., Llor X., Pons E., et al. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99 (2007) 244-252
23. Kumar R., Angelini S., Czene K., et al. BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res 9 (2003) 3362-3368
24. Maruta H., Holden J., Sizeland A., et al. The residues of Ras and Rap proteins that determine their GAP specificities. J Biol Chem 266 (1991) 11661-11668
25. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793
26. Yang A.S., Estecio M.R., Doshi K., et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32 (2004) e38
27. Yang A.S., Doshi K.D., Choi S.W., et al. DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res 66 (2006) 5495-5503
28. Matsuzaki K., Deng G., Tanaka H., et al. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 11 (2005) 8564-8569
29. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
30. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
31. Ogino S., Cantor M., Kawasaki T., et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55 (2006) 1000-1006
32. Issa J.P. CpG island methylator phenotype in cancer. Nat Rev Cancer 4 (2004) 988-993
33. Toyota M., Ohe-Toyota M., Ahuja N., et al. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97 (2000) 710-715
34. Ogino S., Kawasaki T., Kirkner G.J., et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9 (2007) 305-314
35. Nagasaka T., Koi M., Kloor M., et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 134 (2008) 1950-1960
36. Joensuu E.I., Abdel-Rahman W.M., Ollikainen M., et al. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Cancer Res 68 (2008) 4597-4605
37. Bettstetter M., Dechant S., Ruemmele P., et al. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res 13 (2007) 3221-3228
38. Ogino S., Kawasaki T., Nosho K., et al. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122 (2008) 2767-2773
39. Suzuki K., Suzuki I., Leodolter A., et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9 (2006) 199-207
40. Rodriguez J., Frigola J., Vendrell E., et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66 (2006) 8462-9468
41. Pogribny I.P., and Beland F.A. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 66 (2009) 2249-2261
42. Roman-Gomez J., Jimenez-Velasco A., Agirre X., et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24 (2005) 7213-7223
43. Ogino S., Nosho K., Kirkner G.J., et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100 (2008) 1734-1738
44. Guerrero S., Casanova I., Farre L., et al. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Res 60 (2000) 6750-6756